Camrelizumab (Camre) plus taxane-based chemotherapy (CT): Clinical outcomes and dynamic monitoring of CEA as a predictive biomarker of response in patients with recurrent or advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Kong, Cheng
Xu, Jianhua
Jiang, Ming
Zhu, Xiangzhi
Ye, Jinjun
Yu, Shaorong
Zhu, Jun
机构：
[1] Jiangsu Canc Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy
    Lim, Yoojoo
    Keam, Bhumsuk
    Koh, Youngil
    Kim, Tae Min
    Lee, Se-Hoon
    Hah, J. Hun
    Kwon, Tack-Kyun
    Kim, Dong-Wan
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Heo, Dae Seog
    Kim, Kwang Hyun
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 116 (01): : 55 - 60
  • [42] Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial
    Luo, Huiyan
    Lu, Jin
    Bai, Yuxian
    Mao, Teng
    Wang, Jun
    Fan, Qingxia
    Zhang, Yiping
    Zhao, Kuaile
    Chen, Zhendong
    Gao, Shegan
    Li, Jiancheng
    Fu, Zhichao
    Gu, Kangsheng
    Liu, Zhihua
    Wu, Lin
    Zhang, Xiaodong
    Feng, Jifeng
    Niu, Zuoxing
    Ba, Yi
    Zhang, Helong
    Liu, Ying
    Zhang, Li
    Min, Xuhong
    Huang, Jing
    Cheng, Ying
    Wang, Dong
    Shen, Yu
    Yang, Qing
    Zou, Jianjun
    Xu, Rui-Hua
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (10): : 916 - 925
  • [43] A randomized, placebo-controlled, phase III trial-in-progress to evaluate the efficacy and safety of tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma (ESCC).
    Xu, Jian-Ming
    Kato, Ken
    Hubner, Richard
    Raymond, Eric
    Xu, Yihuan
    Liu, Sumei
    Qazi, Ibrahim
    Yoon, Harry H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients
    Sato, Hiroki
    Tsukahara, Kiyoaki
    Okamoto, Isaku
    Katsube, Yasuaki
    Shimizu, Akira
    Kondo, Takahito
    Hanyu, Kenji
    Fushimi, Chihiro
    Okada, Takuro
    Miura, Kouki
    ACTA OTO-LARYNGOLOGICA, 2019, 139 (02) : 201 - 205
  • [45] Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.
    Wang, Xi
    Chang, Bo
    Chen, Xuelian
    Mo, Hongnan
    Wu, Dawei
    Lan, Bo
    Li, Qun
    Xu, Binghe
    Huang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Response characteristics of tislelizumab (TIS) plus chemotherapy (chemo) in first-line (1L) treatment of locally advanced or metastatic esophageal squamous cell carcinoma (ESCC): A post hoc analysis of RATIONALE-306.
    Li, Yi
    Zhao, Chuanhua
    Liu, Rongrui
    Xu, Sheng
    Miao, Xiaojie
    Xu, Jianming
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 413 - 413
  • [47] MMP-9/ANC score as a predictive biomarker for efficacy of bevacizumab plus platinum doublet chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer
    Hiura, Kazuya
    Shiraishi, Akiko
    Suzuki, Chinami
    Takamura, Kei
    Yamamoto, Makoto
    Komori, Hitoshi
    Watanabe, Yasuhiro
    Iwaki-Egawa, Sachiko
    CANCER BIOMARKERS, 2015, 15 (04) : 433 - 440
  • [48] Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma
    Liu, Ying
    Xu, Shu Ning
    Chen, Yong Shun
    Wu, Xiao Yuan
    Qiao, Lei
    Li, Ke
    Yuan, Long
    ONCOTARGET, 2016, 7 (28) : 44330 - 44339
  • [49] A CT-based novel model to predict pathological complete response of locally advanced esophageal squamous cell carcinoma to neoadjuvant PD-1 blockade in combination with chemotherapy
    Zhou, Hai-ying
    Guo, Wen-wen
    Ou, Jing
    Li, Rui
    Gui, Yan
    Li, Li
    Fu, Mao-yong
    Zhang, Xiao-ming
    Chen, Tian-wu
    EUROPEAN JOURNAL OF RADIOLOGY, 2023, 167
  • [50] Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy
    Chen, Wei
    Li, Dapeng
    Bian, Xuyu
    Wu, Yan
    Xu, Mengdan
    Wu, Mengyao
    Tao, Min
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 75 (01): : 207 - 218
12345